Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease

International Heart Journal

Volumn 56, Issue 1, 2015, Pages 29-36

  Miyazaki, Toru ^a,b   Ashikaga, Takashi ^b   Ohigashi, Hirokazu ^a   Komura, Masatoshi ^a   Kobayashi, Kazuo ^a   Isobe, Mitsuaki ^b  

^a Department of Cardiovascular Medicine Kashiwa Municipal Hospital   (China)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Coronary microvascular dysfunction; Index of microcirculatory resistance

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; END DIASTOLIC VOLUME INDEX; END SYSTOLIC VOLUME INDEX; FEMALE; FRACTIONAL FLOW RESERVE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; INDEX OF MICROCIRCULATORY RESISTANCE; MALE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SMOKING; STENOSIS; CORONARY BLOOD VESSEL; JAPAN; MICROCIRCULATION; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RETROSPECTIVE STUDY; STATISTICS; VASCULAR RESISTANCE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; JAPAN; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING; STATISTICS AS TOPIC; VASCULAR RESISTANCE;

EID: 84921851185     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-189     Document Type: Article

References (41)

1. Pupita G, Maseri A, Kaski JC, et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med 1990; 323: 514-20.
2. Aarnoudse W, Fearon WF, Manoharan G, et al. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 2004; 110: 2137-42.
3. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for in-vasively assessing the coronary microcirculation. Circulation 2003; 107: 3129-32.
4. Czernin J, Sun K, Brunken R, Böttcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood fow and fow reserve. Circulation 1995; 91: 2891-7.
5. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-100.
6. Lavi S, Prasad A, Yang EH, et al. Smoking is associated with epi-cardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 2007; 115: 2621-7.
7. Yong AS, Ho M, Shah MG, Ng MK, Fearon WF. Coronary micro-circulatory resistance is independent of epicardial stenosis. Circ Cardiovasc Interv 2012; 5: 103-8.
8. Aarnoudse W, van den Berg P, van de Vosse F, et al. Myocardial resistance assessed by guidewire-based pressure-temperature measurement: in vitro validation. Catheter Cardiovasc Interv 2004; 62: 56-63.
9. Melikian N, Vercauteren S, Fearon WF, et al. Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis. EuroIntervention 2010; 5: 939-45.
10. Layland J, MacIsaac AI, Burns AT, et al. When collateral supply is accounted for epicardial stenosis does not increase microvascular resistance. Circ Cardiovasc Interv 2012; 5: 97-102.
11. Lim CC, van Gaal WJ, Testa L, et al. With the “universal defni-tion,” measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol 2011; 57: 653-61.
12. Lapeyre AC 3rd, Goraya TY, Johnston DL, Gibbons RJ. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol 2004; 11: 506-11. (Review)
13. Kubo S, Tadamura E, Toyoda H, et al. Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole. J Nucl Cardiol 2004; 5: 730-8.
14. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemody-namic dependence of index of microcirculatory resistance compared with coronary fow reserve. Circulation 2006; 113: 2054-61.
15. Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L. Three-dimensional and two-dimensional quantitative coronary an-giography, and their prediction of reduced fractional fow reserve. Eur Heart J 2011; 32: 345-53.
16. Legalery P, Seronde MF, Meneveau N, Schiele F, Bassand JP. Measuring pressure-derived fractional fow reserve through four French diagnostic catheters. Am J Cardiol 2003; 91: 1075-78.
17. De Bruyne B, Pijls NH, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: experimental validation. Circulation 2001; 104: 2003-6.
18. Pijls NH, De Bruyne B, Smith L, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 2002; 105: 2482-6.
19. Yong AS, Layland J, Fearon WF, et al. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardio-vasc Interv 2013; 6: 53-8.
20. Fearon WF, Shah M, Ng M, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008; 51: 560-5.
21. Cuisset T, Hamilos M, Melikian N, et al. Direct stenting for stable angina pectoris is associated with reduced periprocedural micro-circulatory injury compared with stenting after pre-dilation. J Am Coll Cardiol 2008; 51: 1060-5.
22. Ito N, Nanto S, Doi Y, et al. Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocar-dial infarction. Circ J 2011; 75: 94-8.
23. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries: observation on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 1975; 36: 579-89.
24. Campisi R, Czernin J, Schöder H, et al. Effects of long-term smoking on myocardial blood fow, coronary vasomotion, and vasodilator capacity. Circulation 1998; 98: 119-25.
25. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipo-proteins: outcomes from a randomized clinical trial. Am Heart J 2011; 161: 145-51.
26. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298: 784-8.
27. Waters D, Lespérance J, Gladstone P, et al. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation 1996; 94: 614-21.
28. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96: 3243-7.
29. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-40. (Review)
30. Naya M, Morita K, Yoshinaga K, et al. Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers. Eur J Nucl Med Mol Imaging 2011; 38: 491-8.
31. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipo-proteins: outcomes from a randomized clinical trial. Am Heart J 2011; 161: 145-51.
32. van Berkel TF, Boersma H, Roos-Hesselink JW, Erdman RA, Simoons ML. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J 1999; 20: 1773-82. (Review)
33. Morita K, Tsukamoto T, Naya M, et al. Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers. J Nucl Med 2006; 47: 1914-20.
34. Miwa K, Fujita M, Miyagi Y. Benefcial effects of smoking cessation on the short-term prognosis for variant angina--validation of the smoking status by urinary cotinine measurements. Int J Cardiol 1994; 44: 151-6.
35. Saxena A, Shan L, Reid C, et al. Impact of smoking status on early and late outcomes after isolated coronary artery bypass graft surgery. J Cardiol 2013; 61: 336-41.
36. Kern MJ. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 2000; 101:1344-51. (Review)
37. de Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wi-jns W. Simultaneous coronary pressure and fow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996; 94: 1842-9.
38. Fearon WF, Low AF, Yong AS, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 2013; 127: 2436-41.
39. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascu-lar reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010; 55: 2825-32.
40. Fichtlscherer S, Schmidt-Lucke C, Bojunga S, et al. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy. Eur Heart J 2006; 27: 1182-90.
41. Kondo T, Osugi S, Shimokata K, et al. Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J 2011; 75: 2885-92.